RxDoctor Payments Data

Morgan Bunch, APRN

Family · Owensboro, KYNPI 1669117834

Payments from drug & device makers

$1,251in general payments, 2019–2025

Across 90 payments — averaging $13.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$436
  • Amgen$129
  • Boehringer Ingelheim$107
  • AstraZeneca$66
  • Sanofi-aventis U.S. LLC$52
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$52
  • plus $409 from 16 others

What the payments were for

  • Food & beverage$1,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,251 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$18,041
Medicare patients
104
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban150$117,425
EntrestoSacubitril/Valsartan67$63,157
BrilintaTicagrelor25$18,411
XareltoRivaroxaban20$15,701
JardianceEmpagliflozin13$9,088
Metoprolol Succinate304$2,042
Ranolazine ErRanolazine34$1,775
Isosorbide Mononitrate ErIsosorbide Mononitrate124$1,157
Atorvastatin Calcium122$898
ClopidogrelClopidogrel Bisulfate132$893
Carvedilol138$826
Digoxin19$708
Rosuvastatin Calcium82$610
Amlodipine Besylate146$563
Ezetimibe52$561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$436$63,15767 claims
AstraZenecaBrilinta$66$18,41125 claims
Johnson & JohnsonXarelto$41$15,70120 claims
Boehringer IngelheimJardiance$107$9,08813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →